Drugs / BMS-986172
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04926051 | Jun → Dec 2021 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-986172 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04926051 ↗ |
| Modality | Small molecule | — CHEMBL5418882 ↗ |